Literature DB >> 11876412

Secretion of human interferon alpha 2b by Streptomyces lividans.

E Pimienta1, R Fando, J C Sánchez, C Vallin.   

Abstract

Biologically active human interferon alpha 2b (HuIFNalpha-2b) was secreted into the culture medium by Streptomyces lividans transformed with recombinant plasmids coding for HuIFNalpha-2b fused to the Streptomyces exfoliatus M11 lipase A signal sequence. Levels were low, 15 or 100 ng/ml, depending on the plasmid used. Neither processed nor unprocessed HuIFNalpha-2b was detected in cell lysates of the transformants secreting the recombinant product. However, the secreted recombinant product was found to partially degrade when cultures reached the stationary phase by the action of an, as yet, unidentified mycelium-associated factor. Experimental evidence suggests that the degrading factor is related to mycelium-associated proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11876412     DOI: 10.1007/s00253-001-0873-8

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

1.  Large-scale production of a thermostable Rhodothermus marinus cellulase by heterologous secretion from Streptomyces lividans.

Authors:  Mohamed Belal Hamed; Spyridoula Karamanou; Solveig Ólafsdottir; Joana Sofia Martins Basílio; Kenneth Simoens; Kostantinos C Tsolis; Lieve Van Mellaert; Eik Elísabet Guðmundsdóttir; Gudmundur Oli Hreggvidsson; Jozef Anné; Kristel Bernaerts; Olafur H Fridjonsson; Anastassios Economou
Journal:  Microb Cell Fact       Date:  2017-12-23       Impact factor: 5.328

2.  Recombinant production of Streptococcus equisimilis streptokinase by Streptomyces lividans.

Authors:  Elsa Pimienta; Julio C Ayala; Caridad Rodríguez; Astrid Ramos; Lieve Van Mellaert; Carlos Vallín; Jozef Anné
Journal:  Microb Cell Fact       Date:  2007-07-05       Impact factor: 5.328

3.  Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells.

Authors:  Martin Loignon; Sylvie Perret; John Kelly; Denise Boulais; Brian Cass; Louis Bisson; Fatemeh Afkhamizarreh; Yves Durocher
Journal:  BMC Biotechnol       Date:  2008-08-27       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.